TR199902383T2 - Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses. - Google Patents

Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.

Info

Publication number
TR199902383T2
TR199902383T2 TR1999/02383T TR9902383T TR199902383T2 TR 199902383 T2 TR199902383 T2 TR 199902383T2 TR 1999/02383 T TR1999/02383 T TR 1999/02383T TR 9902383 T TR9902383 T TR 9902383T TR 199902383 T2 TR199902383 T2 TR 199902383T2
Authority
TR
Turkey
Prior art keywords
pyrimidine derivatives
preparation
new pyrimidine
new
intermediates
Prior art date
Application number
TR1999/02383T
Other languages
English (en)
Turkish (tr)
Inventor
Wook Lee Jong
Yong Lee Bong
Seop Kim Chang
Kyu Lee Seung
Seog Song Keun
Jin Lee Song
Jeon Shim Woo
Soon Hwang Man
Original Assignee
Yuhan Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corporation filed Critical Yuhan Corporation
Publication of TR199902383T2 publication Critical patent/TR199902383T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1999/02383T 1997-03-27 1998-03-24 Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses. TR199902383T2 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19970010862 1997-03-27
KR19970010863 1997-03-27
PCT/KR1998/000058 WO1998043968A1 (en) 1997-03-27 1998-03-24 Novel pyrimidine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
TR199902383T2 true TR199902383T2 (xx) 2000-06-21

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02383T TR199902383T2 (xx) 1997-03-27 1998-03-24 Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.

Country Status (21)

Country Link
US (1) US6352993B1 (forum.php)
EP (1) EP1015444B1 (forum.php)
JP (1) JP3176379B2 (forum.php)
KR (1) KR100278857B1 (forum.php)
CN (1) CN1118464C (forum.php)
AR (1) AR012181A1 (forum.php)
AT (1) ATE241613T1 (forum.php)
AU (1) AU720385B2 (forum.php)
BR (1) BR9808070A (forum.php)
CA (1) CA2284795C (forum.php)
DE (1) DE69815126T2 (forum.php)
DK (1) DK1015444T3 (forum.php)
ES (1) ES2200324T3 (forum.php)
HU (1) HUP0000851A3 (forum.php)
IN (1) IN188411B (forum.php)
PT (1) PT1015444E (forum.php)
RU (1) RU2203894C2 (forum.php)
TR (1) TR199902383T2 (forum.php)
TW (1) TW542831B (forum.php)
UY (1) UY24938A1 (forum.php)
WO (1) WO1998043968A1 (forum.php)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TW200302728A (en) 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
JP4634144B2 (ja) 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
EP1648877A1 (en) * 2003-07-22 2006-04-26 Neurogen Corporation Substituted pyridin-2-ylamine analogues
WO2005039506A2 (en) * 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
JP2009511548A (ja) * 2005-10-14 2009-03-19 ノイロサーチ アクティーゼルスカブ 新規ピリミジン−２，４−ジアミン誘導体及び小コンダクタンスのカルシウム依存性カリウムチャネルのモジュレーターとしてのこれらの使用
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
WO2010016490A1 (ja) 2008-08-05 2010-02-11 第一三共株式会社 イミダゾピリジン－２－オン誘導体
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CA2817165A1 (en) 2010-11-15 2012-05-24 Patrick Chaltin Novel antiviral compounds
MX337477B (es) 2011-02-25 2016-03-07 Yuhan Corp Derivados de diaminopiridina y procesos para su preparacion.
CA2864825C (en) * 2012-02-17 2021-01-26 Abbvie Inc. Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
IN2014MN02314A (forum.php) 2012-05-29 2015-08-07 Momentive Performance Mat Inc
HK1215032A1 (zh) 2012-11-21 2016-08-12 Ptc Therapeutics, Inc. 取代的反向嘧啶bmi-1抑制劑
MX2015011898A (es) 2013-03-13 2016-05-05 Genentech Inc Compuestos de pirazolo y usos de los mismos.
CA2922657C (en) * 2013-08-30 2022-04-12 Ptc Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
JP6507157B2 (ja) * 2013-10-07 2019-04-24 カドモン コーポレイション，リミティド ライアビリティ カンパニー Ｒｈｏキナーゼ阻害剤
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN107206004A (zh) * 2014-10-22 2017-09-26 德克萨斯大学系统董事会 靶向盘状结构域受体1的小分子抑制剂及其用途
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
UA125377C2 (uk) * 2016-01-04 2022-03-02 Мерк Сероно С.А. L-валінат карбоксамідного похідного гідроксипропілтіазолідину та його сольова форма, кристалічна поліморфна форма
US11477982B2 (en) * 2017-04-05 2022-10-25 Bayer Cropscience Aktiengesellschaft 2-amino-5-oxyalkyl-pyrimidine derivatives and their use for controlling undesired plant growth
JP2021535198A (ja) 2018-08-17 2021-12-16 ピーティーシー セラピューティクス， インコーポレイテッド 膵臓癌を治療する方法
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
TR25912A (tr) 1989-03-22 1993-11-01 Ciba Geigy Ag 2-ANILIN-PRIMIDIN TüREVLERI BU MADDELERINELDE EDIL MELERI VE ZARARLILARA KARSI MüCADELEDE KULLANILMA- LARI
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
FI932032L (fi) 1990-11-06 1993-05-05 Pfizer Kinazolinderivat foer oekande av antitumoeraktivitet
DK0580753T3 (da) * 1991-04-17 1995-07-03 Pfizer Pyrimidinderivater til forøgelse af antitumoraktivitet
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
WO1995005363A1 (en) * 1993-08-12 1995-02-23 Astra Aktiebolag Amidine derivatives with nitric oxide synthetase activities
DK0640599T3 (da) 1993-08-26 1998-09-28 Ono Pharmaceutical Co 4-Aminopyrimidin-derivater
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
CA2197298C (en) * 1994-08-13 1999-10-19 Jong Wook Lee Novel pyrimidine derivatives and processes for the preparation thereof
DK0900214T3 (da) 1996-05-04 2002-01-28 Yuhan Corp Fremgangsmåde til fremstilling af pyrmidin-derivater

Also Published As

Publication number Publication date
ES2200324T3 (es) 2004-03-01
KR100278857B1 (ko) 2001-01-15
PT1015444E (pt) 2003-10-31
RU2203894C2 (ru) 2003-05-10
BR9808070A (pt) 2000-03-08
HUP0000851A3 (en) 2002-04-29
JP2000513014A (ja) 2000-10-03
EP1015444B1 (en) 2003-05-28
DK1015444T3 (da) 2003-08-18
IN188411B (forum.php) 2002-09-21
CA2284795C (en) 2004-01-20
HK1026418A1 (en) 2000-12-15
KR19980080789A (ko) 1998-11-25
US6352993B1 (en) 2002-03-05
JP3176379B2 (ja) 2001-06-18
DE69815126T2 (de) 2004-04-08
CN1118464C (zh) 2003-08-20
TW542831B (en) 2003-07-21
HUP0000851A1 (hu) 2001-04-28
EP1015444A1 (en) 2000-07-05
AR012181A1 (es) 2000-09-27
AU720385B2 (en) 2000-06-01
CN1251586A (zh) 2000-04-26
WO1998043968A1 (en) 1998-10-08
CA2284795A1 (en) 1998-10-08
DE69815126D1 (de) 2003-07-03
ATE241613T1 (de) 2003-06-15
UY24938A1 (es) 2001-01-31
AU6523998A (en) 1998-10-22

Similar Documents

Publication Publication Date Title
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
TR200101764T2 (tr) Yeni bileşikler.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
TR199902082T2 (xx) Pirazin bile�ikleri.
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
TR200101412T2 (tr) Yeni bileşikler.
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
DE69516847D1 (de) Chlorpyrimidine als zwischenprodukte
TR199802344A2 (xx) �kame edilmi� imidazolidin t�revleri
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
TR199903214T2 (xx) Bir antit�m�r maddesi ve bir hidroksimik asit t�revini ihtiva eden, antit�m�r etkinli�i artt�r�lm�� ve yan etkileri d���r�lm�� farmas�tik bile�im.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
TR200400187T2 (tr) Yeni oral formülasyon.
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
TR199700261A2 (xx) Yeni Pirimido (1,2-a) indoller.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
TR200002461T2 (tr) Streptogramin türevleri, hazırlanışları ve bunları içeren bileşimler.
UY26426A1 (es) Nuevos compuestos
SE9803272D0 (sv) A drug for cell regeneration
IL134930A0 (en) Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same